TABLE OF CONTENTS
Volume 33, Issue 10 (May (2) 2004)
Conditioning Regimens |
Dendritic Cells |
Progenitor Cell Mobilization |
Myelofibrosis |
Lymphoma |
Graft-Versus-Host Disease |
Graft Rejection |
Post-Transplant Complications |
Case Reports |
Correspondence
Editorial
Liver disease of uncertain cause FREE
G B McDonald
Bone Marrow Transplant 33: 977-978; advance online publication, April 5, 2004; doi:10.1038/sj.bmt.1704464
Conditioning Regimens
I.V. busulfan in pediatrics: a novel dosing to improve safety/efficacy for hematopoietic progenitor cell transplantation recipients FREE
L Nguyen, D Fuller, S Lennon, F Leger and C Puozzo
Bone Marrow Transplant 33: 979-987; advance online publication, April 5, 2004; doi:10.1038/sj.bmt.1704446
Dendritic Cells
Blood dendritic cells are decreased in acute graft-versus-host disease FREE
M Takebayashi, R Amakawa, K Tajima, M Miyaji, K Nakamura, T Ito, N Matsumoto, Y Miyazaki, K Zen, Y Kishimoto and S Fukuhara
Bone Marrow Transplant 33: 989-996; advance online publication, April 5, 2004; doi:10.1038/sj.bmt.1704406
Progenitor Cell Mobilization
Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost FREE
S Boeve, J Strupeck, S Creech and P J Stiff
Bone Marrow Transplant 33: 997-1003; advance online publication, April 5, 2004; doi:10.1038/sj.bmt.1704486
Myelofibrosis
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia FREE
P Mittal, R M Saliba, S A Giralt, M Shahjahan, A I Cohen, S Karandish, F Onida, M Beran, R E Champlin and M de Lima
Bone Marrow Transplant 33: 1005-1009; advance online publication, March 29, 2004; doi:10.1038/sj.bmt.1704472
Lymphoma
High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma FREE
A S Buser, D Heim, C Bucher, A Tichelli, A Gratwohl and J R Passweg
Bone Marrow Transplant 33: 1011-1014; advance online publication, April 5, 2004; doi:10.1038/sj.bmt.1704489
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma FREE
U Popat, C Hosing, R M Saliba, P Anderlini, K van Besien, D Przepiorka, I F Khouri, J Gajewski, D Claxton, S Giralt, M Rodriguez, J Romaguera, F Hagemeister, C Ha, J Cox, F Cabanillas, B S Andersson and R E Champlin
Bone Marrow Transplant 33: 1015-1023; advance online publication, March 29, 2004; doi:10.1038/sj.bmt.1704483
Graft-Versus-Host Disease
Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation FREE
D H Kim, S K Sohn, J G Kim, J S Suh, K S Lee and K B Lee
Bone Marrow Transplant 33: 1025-1030; advance online publication, April 5, 2004; doi:10.1038/sj.bmt.1704479
Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease FREE
M R Robinson, S S Lee, B I Rubin, A S Wayne, S Z Pavletic, M R Bishop, R Childs, A J Barrett and K G Csaky
Bone Marrow Transplant 33: 1031-1035; advance online publication, March 29, 2004; doi:10.1038/sj.bmt.1704453
Graft Rejection
Successful treatment of incipient graft rejection with donor leukocyte infusions, further proof of a graft versus host lymphohaemopoietic effect FREE
J L Díez-Martín, A Gómez-Pineda, D Serrano, R Carrión, P Balsalobre and I Buño
Bone Marrow Transplant 33: 1037-1041; advance online publication, April 5, 2004; doi:10.1038/sj.bmt.1704488
Post-Transplant Complications
Predictors for severe cardiac complications after hematopoietic stem cell transplantation FREE
M Sakata-Yanagimoto, Y Kanda, M Nakagawa, Y Asano-Mori, K Kandabashi, K Izutsu, Y Imai, A Hangaishi, M Kurokawa, S Tsujino, S Ogawa, S Chiba, T Motokura and H Hirai
Bone Marrow Transplant 33: 1043-1047; advance online publication, April 5, 2004; doi:10.1038/sj.bmt.1704487
Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood FREE
B Bakker, W Oostdijk, D Bresters, M J E Walenkamp, J M Vossen and J M Wit
Bone Marrow Transplant 33: 1049-1056; advance online publication, March 29, 2004; doi:10.1038/sj.bmt.1704481
Case Reports
Horse antilymphocytic globulin in hepatitis B exacerbation after bone marrow transplantation adoptive immunity transfer FREE
C Favre, M C Menconi, M Nardi, G Casazza, F Oliveri, P Macchia, F Bonino and M R Brunetto
Bone Marrow Transplant 33: 1057-1059; advance online publication, March 29, 2004; doi:10.1038/sj.bmt.1704471
Nonmyeloablative allogeneic bone marrow transplantation for treatment of childhood overlap syndrome and small vessel vasculitis FREE
O Y Jones, R A Good and R A Cahill
Bone Marrow Transplant 33: 1061-1063; advance online publication, March 29, 2004; doi:10.1038/sj.bmt.1704482
Correspondence
Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease FREE
A Verma, S Williams, S Trifilio, T Zembower and J Mehta
Bone Marrow Transplant 33: 1065-1066; advance online publication, March 29, 2004; doi:10.1038/sj.bmt.1704485
Single-agent high-dose melphalan followed by peripheral blood stem cell (PBSC) in lymphoma patients: an effective, and well-tolerated conditioning regimen FREE
M Magagnoli, L Castagna, S Bramanti, M Balzarotti and A Santoro
Bone Marrow Transplant 33: 1067-1068; advance online publication, April 15, 2004; doi:10.1038/sj.bmt.1704492
Chemotherapy and donor leukocyte infusions for relapsed juvenile myelomonocytic leukemia (JMML) FREE
S Neudorf, A Nourani, P Kempert, V Shen, L Sender and I Kirov
Bone Marrow Transplant 33: 1069; advance online publication, April 5, 2004; doi:10.1038/sj.bmt.1704478
Rituximab and autologous stem cell transplantation for malignant lymphoma after liver transplantation FREE
B Sánchez-González, P Fernández-Abellán, MC Garcia Garay, B Villarrubia, M F Palmero and C Rivas
Bone Marrow Transplant 33: 1071-1072; advance online publication, March 22, 2004; doi:10.1038/sj.bmt.1704468
